COVID-19 Antiviral Agents and COVID-19 Rebound

0 Views· 11/22/22
CCO Infectious Disease Podcast
0

In this episode, Jason Gallagher, PharmD, and Emily Heil, PharmD, MS, BCIDP discuss landmark clinical trials of COVID-19 antivirals for nonhospitalized patients and COVID-19 rebound phenomenon, including:  EPIC-HR study of nirmatrelvir plus ritonavirPINETREE study of remdesivirMOVe-OUT and Panoramic studies of molnupiravirCOVID-19 rebound in treated and untreated patientsPresenters:Jason Gallagher, PharmD<br />Clinical Professor<br />School of Pharmacy<br />Temple University<br />Clinical Pharmacy Specialist<br />Infectious Diseases<br />Temple University Hospital<br />Philadelphia, PennsylvaniaEmily Heil, PharmD, MS, BCIDP, AAHIVP<br />Associate Professor<br />Department of Pharmacy Practice and Science<br />University of Maryland School of Pharmacy<br />Infectious Diseases Clinical Pharmacy Specialist<br />University of Maryland Medical Center<br />Baltimore, Maryland 

Show more

 0 Comments sort   Sort By


Up next